Cyclosporine A Shields the Brain After Stroke and Restores ER-Mitochondria Contact in Mice
In mice and neuronal-like cells, cyclosporine A reduced stroke damage and shifted ER-mitochondria coupling, mitophagy markers and calcium handling.
Summary
After a stroke, restoring blood flow can paradoxically cause further brain damage. Part of that injury comes from mitochondria, the cell's power plants, becoming overloaded with calcium and failing to clear damaged units. This study tested cyclosporine A, an established immunosuppressant, in male mice with experimental stroke (middle cerebral artery occlusion followed by reperfusion). Treated mice had smaller infarcts, less blood-brain barrier leakage and better neurological and motor performance. In PC12 cells (a rat neuron-like line) deprived of oxygen and glucose, the drug increased markers of contact between the endoplasmic reticulum and mitochondria (IP3R-VDAC1) and of mitophagy-related proteins (LC3B-FUNDC1), and lowered intracellular calcium. The findings are associations only. The authors state that genetic and mitophagy-flux experiments are still needed to show this pathway is required for the protection. Nothing here shows benefit in people, and lifespan was not studied.
Detailed Summary
Brain aging raises the odds of stroke, and recovery from stroke is limited by reperfusion injury: when blood returns, calcium overload and mitochondrial failure add to the damage. Protecting mitochondria and the clearance of damaged ones (mitophagy) is a mechanism of broad interest in brain aging.
This preclinical study examined cyclosporine A, a drug long known to act on mitochondria. Male C57BL/6J mice were assigned to control, middle cerebral artery occlusion/reperfusion (MCAO/R), or MCAO/R plus cyclosporine A. Researchers measured infarct volume, blood-brain barrier permeability (Evans Blue extravasation), neurological deficits and motor performance. Separately, PC12 cells underwent oxygen-glucose deprivation/reoxygenation (OGD/R) with or without the drug. Immunofluorescence assessed IP3R-VDAC1 colocalization (a proxy for ER-mitochondria contact) and LC3B-FUNDC1 colocalization (a mitophagy-related readout), and Fluo-4 AM flow cytometry and confocal imaging measured intracellular calcium.
In mice, cyclosporine A was associated with smaller infarcts, less Evans Blue leakage and better neurological and motor outcomes. That is a function and tissue-damage result. In OGD/R cells, the drug increased both colocalization measures and reduced calcium accumulation. That is a mechanistic signal, tied to the drug only by association.
The proposed picture is that cyclosporine A helps restore ER-mitochondria coupling, aiding calcium handling and FUNDC1-linked mitophagy. This is a plausible link between a known drug and a mitochondrial quality-control pathway worth following.
Caveats matter. The authors explicitly note that genetic and mitophagy-flux studies are needed to test whether the pathway is necessary for protection. Colocalization is not flux. Only male mice and a cell line were used, and the abstract reports no lifespan or human data. This summary is based on the abstract only.
Key Findings
- In male mice with MCAO/R stroke, cyclosporine A was associated with reduced infarct volume and less blood-brain barrier leakage (Evans Blue).
- Function: treated mice showed improved neurological scores and motor performance after MCAO/R.
- Mechanism: in OGD/R PC12 cells, the drug increased IP3R-VDAC1 and LC3B-FUNDC1 colocalization and lowered intracellular calcium.
- Authors say genetic and mitophagy-flux studies are needed to show the ER-mitochondria-FUNDC1 pathway is necessary for protection.
Methodology
Preclinical study with three mouse groups (control, MCAO/R, MCAO/R plus cyclosporine A) in male C57BL/6J mice, plus an OGD/R model in PC12 cells with or without the drug. Outcomes were infarct volume, Evans Blue permeability, neurological and motor tests, immunofluorescence colocalization and Fluo-4 AM calcium imaging. Group sizes, dosing and timing were not available in the abstract.
Study Limitations
This summary is based on the abstract only. Evidence is associative, and colocalization is not mitophagy flux; no genetic necessity tests were done. Only male mice and a rat neuron-like cell line were used, with no lifespan, aged-animal or human data, and sample sizes and dosing were not reported in the abstract.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
